Association between the osmotic fragility of erythrocytes and the course of acute myocardial infarction

Aim.      To investigate the relationship between the osmotic fragility of erythrocytes and the course of acute myocardial infarction (MI).

Methods.           An analysis of the osmotic fragility of erythrocytes was conducted using beta-blocker-based osmotic fragility test in sixty-two patients within the first 6 hours after onset of MI symptoms.

Results. The results revealed that the patients with increased erythrocyte osmotic fragility experienced more complications after acute MI, such as left ventricular failure and cardiac arrhythmias (ventricular extrasystoles and ventricular tachycardia) (p = 0.026). Moreover, these patients exhibited greater myocardial injury - the concentration of biomarkers of myocardial necrosis, such as creatine phosphokinase, creatine phosphokinase MB and Troponin I was increased - p = 0.009, p = 0.032 and p = 0.001, respectively. In addition to that, the patients with high osmotic fragility had a larger number of hypokinetic and akinetic segments, high impaired myocardial contractility index, and low ejection fraction. The impaired myocardial contractility index was significantly higher in patients with increased erythrocyte osmotic fragility (1.5 (1.22; 1.75) vs 1.12 (1.0; 1.56), U = 157.5, p = 0.032).

Conclusion. Increased erythrocyte osmotic fragility in patients was associated with greater myocardial injury, manifesting through the higher concentration of biomarkers of myocardial necrosis in blood, as well as higher number of hypokinetic segments.

1. Cardiovascular prevention 2017. National guidelines. Russian Journal of Cardiology. 2018;(6):7-122 (In Russian). doi: 10.15829/1560-4071-2018-6-7-122

2. Glushhenko VA, Irklienko EK. Cardiovascular morbidity — one of the most vital problems of modern health care. Medicine and healthcare organization. 2019;4(1):56-60 (In Russian)

3. Garganeeva AA., Kuzheleva EA., Aleksandrenko VA. Population study of long term outcomes of acute myocardial infarction in Tomsk. Russian Journal of Cardiology. 2017;(11):27-30. (In Russian). doi: 10.15829/1560-4071-2017-11-27-30

4. Vasoregulation. In: Kingma G.J., Simard D., Rouleau R. Jacques. Autonomic Nervous System and Neurocardiac Physiopathology. IntechOpen; 2018:39-46. doi: 10.5772/intechopen.77087

5. Johnson J. O. Autonomic Nervous System: Physiology. In: Hugh C. Hemmings, Talmage D. Egan, editors. Pharmacology and Physiology for Anesthesia. Elsevier; 2019:137-175. ISBN: 978-1-4377-1679-5

6. Karakas M., Koenig W Sympathetic Nervous System. A Crucial Player Modulating Residual Cardiovascular Risk. Circulation Research. 2013;112:13-16. doi: 10.1161/CIRCRESAHA.112.281097

7. Araujo C.G., Laukkanen J.A. Heart and Skeletal Muscles: Linked by Autonomic Nervous System. Arq Bras Cardiol. 2019:112(6):747-748. doi: 10.5935/abc.20190097

8. Bulashova O.V, Malkova M.I. Adrenoreactivity as a prognostic criterion for perioperative cardiac complications in extracardiac surgery. Kazan Medical Journal. 2012;2(93):177-181 (In Russian)

9. Malkova M.I., Bulashova O.V., Khazova E.V. Specification of adrenoreactivity of an organism with adrenoreception of cell membrane in cardiovascular pathology. Practical medicine. 2013;3(13):20-23 (In Russian)

10. Stryuk RI., Dlusskaya IG. Adrenoreactivity and cardiovascular system. Moscow: Medicine: 2003. (In Russian). ISBN: 5-225-04337-2

11. Society of Specialists in Emergency Cardiology. Clinical recommendations: Acute myocardial infarction with ST segment elevation. Ministry of Health of the Russian Federation. 2016:1-13 (In Russian)

12. Aleksandrenko V.A., Rebrova T.Y., Afanasiev S.A., Garganeeva A.A. Association of adrenoreactivity with the stage of chronic heart failure in patients with previous myocardial infarction. The Siberian Medical Journal. 2019;34(2):79-83 (In Russian). doi: 10.29001/2073-8552-2019-34-2-79-83

13. Turishcheva A.P. The prognostic role of the adrenoreactivity indicator during coronary heart disease in patients who have had myocardial infarction at a young age [dissertation]. Moscow; 2005. (In Russian)

14. Aimagambetova A.O., Karazhanova L.K., Kotlyar A. Predictors of the complicated course of myocardial infarction. Actual scientific researches in the modern world. 2017:6-2(26):13-18 (In Russian)

15. Barbarash O.L., Kashtalap V V Fourth universal definition of myocardial infarction. Focus on the type 2 myocardial infarction. Fundamental and clinical medicine. 2018:3(4):73-82 (In Russian). doi:10.23946/2500-0764-2018-3-4-73-82